Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryse Brassard

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biologics : Targets & Therapy|April 14, 2012
Role of vandetanib in the management of medullary thyroid cancerMaryse Brassard, Geneviève Rondeau
The Medical Clinics of North America|August 30, 2008
Basic infertility including polycystic ovary syndromeMaryse Brassard, Youssef AinMelk, Jean-Patrice Baillargeon
Nature Reviews. Endocrinology|August 10, 2011
Treatment and follow-up of low-risk patients with thyroid cancerMartin Schlumberger, Isabelle Borget, Camila Nascimento, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2011
Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancerMaryse Brassard, Barbara Neraud, Séverine Trabado, et al.
Archives of Dermatology|December 19, 2012
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanibDamien Giacchero, Constanza Ramacciotti, Jean Philippe Arnault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2024
Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada's ExperienceFlorence Lévesque, Richard J Payne, Danielle Beaudoin, et al.
European Journal of Endocrinology|January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF networkMarie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
Frontiers in Endocrinology|July 1, 2021
A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid CancerAnna M Sawka, Sangeet Ghai, George Tomlinson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's ExperienceMichael K Gupta, Ana-Maria Misariu, Nadim Saydy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biologics : Targets & Therapy|April 14, 2012
Role of vandetanib in the management of medullary thyroid cancerMaryse Brassard, Geneviève Rondeau
The Medical Clinics of North America|August 30, 2008
Basic infertility including polycystic ovary syndromeMaryse Brassard, Youssef AinMelk, Jean-Patrice Baillargeon
Nature Reviews. Endocrinology|August 10, 2011
Treatment and follow-up of low-risk patients with thyroid cancerMartin Schlumberger, Isabelle Borget, Camila Nascimento, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 2011
Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancerMaryse Brassard, Barbara Neraud, Séverine Trabado, et al.
Archives of Dermatology|December 19, 2012
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanibDamien Giacchero, Constanza Ramacciotti, Jean Philippe Arnault, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2024
Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada's ExperienceFlorence Lévesque, Richard J Payne, Danielle Beaudoin, et al.
European Journal of Endocrinology|January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF networkMarie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
Frontiers in Endocrinology|July 1, 2021
A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid CancerAnna M Sawka, Sangeet Ghai, George Tomlinson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's ExperienceMichael K Gupta, Ana-Maria Misariu, Nadim Saydy, et al.
Pageof 1